175 related articles for article (PubMed ID: 24682792)
21. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
[TBL] [Abstract][Full Text] [Related]
23. Incremental changes verses a technological quantum leap: the additional value of intensity-modulated radiotherapy beyond image-guided radiotherapy for prostate irradiation.
Ratnayake G; Martin J; Plank A; Wong W
J Med Imaging Radiat Oncol; 2014 Aug; 58(4):503-10. PubMed ID: 25243269
[TBL] [Abstract][Full Text] [Related]
24. Written information material and availability of sexual health care for men experiencing sexual dysfunction after prostate cancer treatment: An evaluation of Dutch urology and radiotherapy departments.
Grondhuis Palacios LA; Krouwel EM; Duijn M; den Oudsten BL; den Ouden ME; Putter H; Pelger RC; Elzevier HW
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 28026069
[TBL] [Abstract][Full Text] [Related]
25. Technical Note: Comparison of peripheral patient dose from MR-guided
Hauri P; Hälg RA; Schneider U
Med Phys; 2017 Jul; 44(7):3788-3793. PubMed ID: 28437010
[TBL] [Abstract][Full Text] [Related]
26. PITASOR epidemiological study: prevalence, incidence and treatment of anaemia in radiation therapy oncology departments in Spain.
Samper Ots PM; Muñoz J; Biete A; Ortiz MJ; Acuña M; Cabrera J; López Carrizosa C; Bayo E; Herruzo I; Pérez MM; Domínguez MA; Morillo Macías V; Mira M; Pérez Casas AM; Sevillano MM; García Ríos I; Andreu F; Sotoca A; Álvarez A; López E; Pérez Escutia MÁ; Loayza Villaroel A
Clin Transl Oncol; 2011 May; 13(5):322-7. PubMed ID: 21596660
[TBL] [Abstract][Full Text] [Related]
27. A cost-outcome analysis of Image-Guided Patient Repositioning in the radiation treatment of cancer of the prostate.
Ploquin N; Dunscombe P
Radiother Oncol; 2009 Oct; 93(1):25-31. PubMed ID: 19409635
[TBL] [Abstract][Full Text] [Related]
28. [Advances in highly conformal radiotherapy for prostate cancer: past, current, and future].
Ishikawa H; Hashimoto T; Makishima H; Mizumoto M; Okumura T; Sakurai H
Igaku Butsuri; 2012; 32(3):138-47. PubMed ID: 24592684
[TBL] [Abstract][Full Text] [Related]
29. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
Teh BS; Paulino A; Butler EB
Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
[TBL] [Abstract][Full Text] [Related]
30. Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial.
Keilholz L; Willner J; Thiel HJ; Zamboglou N; Sack H; Popp W
Strahlenther Onkol; 2014 Jan; 190(1):17-25. PubMed ID: 24126939
[TBL] [Abstract][Full Text] [Related]
31. Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.
Nakamura K; Mizowaki T; Inokuchi H; Ikeda I; Inoue T; Kamba T; Ogawa O; Hiraoka M
Int J Clin Oncol; 2018 Feb; 23(1):158-164. PubMed ID: 28756594
[TBL] [Abstract][Full Text] [Related]
32. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398
[TBL] [Abstract][Full Text] [Related]
33. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources.
Esco R; Palacios A; Pardo J; Biete A; Carceller JA; Veiras C; Vazquez G;
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):319-27. PubMed ID: 12738304
[TBL] [Abstract][Full Text] [Related]
34. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
Morimoto M; Yoshioka Y; Konishi K; Isohashi F; Takahashi Y; Ogata T; Koizumi M; Teshima T; Bijl HP; van der Schaaf A; Langendijk JA; Ogawa K
Tumori; 2014; 100(3):265-71. PubMed ID: 25076236
[TBL] [Abstract][Full Text] [Related]
35. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.
Bruner DW; Hunt D; Michalski JM; Bosch WR; Galvin JM; Amin M; Xiao C; Bahary JP; Patel M; Chafe S; Rodrigues G; Lau H; Duclos M; Baikadi M; Deshmukh S; Sandler HM
Cancer; 2015 Jul; 121(14):2422-30. PubMed ID: 25847819
[TBL] [Abstract][Full Text] [Related]
36. Current and Future Challenges of Radiation Oncology in Iran: A Report from the Iranian Society of Clinical Oncology.
Ameri A; Barzegartahamtan M; Ghavamnasiri M; Mohammadpour R; Dehghan H; Sebzari A; Novin K; Aloosh M
Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):262-268. PubMed ID: 29338969
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.
Vu CC; Blas KG; Lanni TB; Gustafson GS; Krauss DJ
Brachytherapy; 2018; 17(6):852-857. PubMed ID: 30076108
[TBL] [Abstract][Full Text] [Related]
38. Radiation oncology in Australia: workforce, workloads and equipment 1986-1999.
Wigg DR; Morgan GW
Australas Radiol; 2001 May; 45(2):146-69. PubMed ID: 11380358
[TBL] [Abstract][Full Text] [Related]
39. A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer.
Li M; Li GF; Hou XY; Gao H; Xu YG; Zhao T
Chin Med J (Engl); 2016 Jun; 129(12):1447-54. PubMed ID: 27270540
[TBL] [Abstract][Full Text] [Related]
40. MR imaging of prostate cancer in radiation oncology: what radiologists need to know.
Boonsirikamchai P; Choi S; Frank SJ; Ma J; Elsayes KM; Kaur H; Choi H
Radiographics; 2013 May; 33(3):741-61. PubMed ID: 23674772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
